| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/08/2005 | CN1204885C Pharmaceutical composition contg. fenofibrate and preparation method |
| 06/08/2005 | CN1204884C N-acetyl-L cysteine for preparing medicine for treating epithelial tumous |
| 06/08/2005 | CN1204883C Low dose diclofenac sodium lozenge and its preparation method |
| 06/08/2005 | CN1204882C Directly compressible, ultra fine acetaminophen compositions and process for producing same |
| 06/08/2005 | CN1204881C Use of allylamine derivatives in the manufacture of a medicament for the treatment of helicobacter pylori infection and correlation diseases |
| 06/08/2005 | CN1204880C Febuprol cyclodextrin clathrate and its preparation |
| 06/08/2005 | CN1204879C Transdermal therapeutic system wit hneutralized pressure sensitivity acrylic adhesive patch |
| 06/08/2005 | CN1204877C Process for preparing solid pharmaceutical dosage forms |
| 06/08/2005 | CN1204875C Delivery system for oral care compositions comprising organosiloxane resins using removable backing strip |
| 06/08/2005 | CN1204859C Transdermal drug delivery matrix for coadministering estradiol and another steroid |
| 06/08/2005 | CN1204819C Fat or oil compsn. |
| 06/08/2005 | CA2452588A1 Methods for the treatment of bipolar disorder using carbamazepine |
| 06/07/2005 | US6903238 Carbocyclic ketones such as 3-Amino-5-hydroxy-2-(4-hydroxy-phenyl)-1H-inden-1-one, used as estrogen receptor modulators |
| 06/07/2005 | US6903235 Pharmaceutical-grade ferric citrate |
| 06/07/2005 | US6903220 Synthesis of chiral 2-alkyl amino acids |
| 06/07/2005 | US6903216 Antiarrhythmic agents for the treatment and prophylaxis of atrial arrhythmias, atrial fibrillation (AF) or atrial flutter; potassium channel modulators, beta-blocker |
| 06/07/2005 | US6903215 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 06/07/2005 | US6903210 Octenidine dihydrochloride, C1 to C8-alkyl alcohol, alkylpolyglycoside non-ionic and quaternary betaine cationic surfactants, water, alpha-hydroxycarboxylic acid |
| 06/07/2005 | US6903203 Immunoglobulin for use in the diagnosis and therapy of cancer |
| 06/07/2005 | US6903199 Crosslinked amide derivatives of hyaluronic acid and manufacturing method thereof |
| 06/07/2005 | US6903137 Agonists specific for the peripheral cannabinoid receptor |
| 06/07/2005 | US6903135 Methods and products related to 16-HETE analogs |
| 06/07/2005 | US6903134 Formulation comprising benzofuranone derivatives for protection against oxidative stress |
| 06/07/2005 | US6903133 Anticancer compounds |
| 06/07/2005 | US6903132 Non-peptide GnRH agents, pharmaceutical compositions and methods for their use |
| 06/07/2005 | US6903131 Administering to a patient an antiangiogenesis or anticancer agent (N,N-disubstituted-3,4-diamino-2,4-dione-pyrroline derivatives for the treatment of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer |
| 06/07/2005 | US6903130 (S)-alpha-ethyl-2-oxo-1-pyrrolidineacetamide stereoisomer for the treatment of bipolar disorders |
| 06/07/2005 | US6903129 D-proline prodrugs |
| 06/07/2005 | US6903128 Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
| 06/07/2005 | US6903127 Sexual disorders |
| 06/07/2005 | US6903123 Antitussive agents, anxiolytic agents, analgesics for treating cough, anxiety and pain |
| 06/07/2005 | US6903122 Crystals of benzimidazole compounds |
| 06/07/2005 | US6903121 Treatment of tumors with acetylenes disubstituted with a phenyl or heteroaromatic group and a substituted chromanyl, thiochromanyl or tetrahydroquinolinyl group in combination with other anti-tumor agents |
| 06/07/2005 | US6903120 Modulators of dopamine neurotransmission |
| 06/07/2005 | US6903115 Bipiperidine compounds |
| 06/07/2005 | US6903112 Nitrogen compounds such as 1-benzenesulfonyl-3-piperidin-3-yl -1H-indole, used as serotonin receptor antagonists, for prophylaxis of nervous system disorders |
| 06/07/2005 | US6903110 Selective serotonin reuptake inhibitors |
| 06/07/2005 | US6903109 Arylindenopyridines and related therapeutic and prophylactic methods |
| 06/07/2005 | US6903107 Serine protease inhibitor |
| 06/07/2005 | US6903106 Nitrogen compounds having improved solubility, bioavailability and stability, used as sedatives, anxiolytics, anticonvulsant, and/ or muscle relaxants for prophylaxis of sleep disorders |
| 06/07/2005 | US6903103 Linear cyclic ureas |
| 06/07/2005 | US6903102 17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
| 06/07/2005 | US6903100 Administering methotrexate at high level to cross the blood brain barrier; methotrexate administration is accompanied by leucovorin rescue of the periphery |
| 06/07/2005 | US6903099 Heterocyclic amides used as preferential inhibitors of cyclic guanosine 3',5'-monophosphate specific phosphodiesterase, for prophylaxis of cardiovascular disorders and erectile dysfunction |
| 06/07/2005 | US6903098 Use of phthalazine derivatives |
| 06/07/2005 | US6903097 Heterocycle carboxamides as antiviral agents |
| 06/07/2005 | US6903096 Quinazoline derivatives as medicaments |
| 06/07/2005 | US6903095 Phthalimido derivatives and a process for their preparation |
| 06/07/2005 | US6903094 As analgesic |
| 06/07/2005 | US6903091 Kidney diseases; hypotensive agents; blood disorders |
| 06/07/2005 | US6903090 Such as 10-(2-ethoxyphenyl)-1,2,3,4,5,6-hexahydroazepino(4,5-b)indole; for treatment of anxiety, depression, schizophrenia, epilepsy, migraine, Alzheimers disease, sleep disorders, obesity, stress related diseases, and/or drug withdrawal |
| 06/07/2005 | US6903089 Lactam-substituted pyrazolopyridine derivatives |
| 06/07/2005 | US6903088 Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 06/07/2005 | US6903087 Pyrido cyclohexenyl phenyl carboxamides tocolytic oxytocin receptor antagonists |
| 06/07/2005 | US6903086 Alkoxycarbonylamino benzoic acid or alkoxycarbonylamino tetrazolyl phenyl derivatives as IP antagonists |
| 06/07/2005 | US6903085 Substituted piperidine compounds useful as modulators of chemokine receptor activity |
| 06/07/2005 | US6903084 Steroid sulphatase inhibitors |
| 06/07/2005 | US6903083 Stabilized hydroxyvitamin D |
| 06/07/2005 | US6903082 Methods of treating inflammatory conditions of the gastrointestinal tract using 4-APAA and compositions thereof |
| 06/07/2005 | US6903081 Phosphoramidates and methods therefor |
| 06/07/2005 | US6903080 Disease treatment with novel phospholipid derivatives |
| 06/07/2005 | US6903078 Applying wound healing agents comprising nucleotide sequences codes for platelet derived growth factors(PDGF), keratinocyte growth factors(KGF), insulin like growth factors(IGF) and insulin like growth factor binding proteins(IGFBP) |
| 06/07/2005 | US6903076 Antihelminthic anthraquinones and method of use thereof |
| 06/07/2005 | US6903052 For controlling nematodes that infest plants or the situs of plants |
| 06/07/2005 | US6902908 Polypeptides, fusion proteins; includes production and use recombinant expression constructs having regulated promoter; mitochondria |
| 06/07/2005 | US6902902 Human G protein-coupled receptors and modulators thereof for the treatment of metabolic-related disorders |
| 06/07/2005 | US6902885 For detecting viral and cellular polypeptide interactions |
| 06/07/2005 | US6902881 Modulating cell proliferation or cell differentiation, comprising treating a cell with a bilin; regulation of neural tissues, bone and cartilage formation and repair, smooth muscle, lung, liver and other organs; cosmetics |
| 06/07/2005 | US6902746 Oral pharmaceutical compositions containing non-steroidal anti-inflammatory drugs and method for preparing the same |
| 06/07/2005 | US6902742 Pulsatile delivery of methylphenidate to treat attention deficit disorder |
| 06/07/2005 | US6902741 Laminates containing an active substance transdermal system |
| 06/07/2005 | US6902739 Administering a stabilized rice bran derivative and a fortification agent; treating bone disorders |
| 06/07/2005 | US6902738 Topical oral dosage forms containing bismuth compounds |
| 06/07/2005 | US6902731 Transcription factors; for arterial administration via stent |
| 06/07/2005 | US6902727 Synergistic mixture of polyacrolein and isothiazolin-3-one compounds |
| 06/07/2005 | US6902721 Inhibitors of proteasomal activity for stimulating bone growth |
| 06/07/2005 | US6902566 Spinal implants, insertion instruments, and methods of use |
| 06/07/2005 | US6901929 Aerosolization; comprises pressurization cylinders; drug delivery |
| 06/07/2005 | CA2464258C Compositions containing piperacillin and tazobactam useful for injection |
| 06/07/2005 | CA2336815C Composition and pharmaceutical dosage form for colonic drug delivery using polysaccharides |
| 06/07/2005 | CA2332686C Novel 13 and 14-membered antibacterial and prokinetic macrolides and their intermediates |
| 06/07/2005 | CA2320180C Cyclohexanediole derivatives |
| 06/07/2005 | CA2299036C 4-phenyl-4-heteroarylpiperidine derivatives |
| 06/07/2005 | CA2281090C Sulfonamide compounds and salts for treatment of endothelin-mediated disorders |
| 06/07/2005 | CA2244139C Distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents |
| 06/07/2005 | CA2234113C Novel derivatives of salicylic acid and their use in a cosmetic and/or dermatological composition |
| 06/07/2005 | CA2225439C Propiophenone derivatives and process for preparing the same |
| 06/07/2005 | CA2209598C Aryl and heteroaryl purine compounds |
| 06/07/2005 | CA2186731C Trinuclear cationic platinum complexes having antitumour activity and pharmaceutical compositions containing them |
| 06/07/2005 | CA2186039C New oral pharmaceutical dosage form |
| 06/07/2005 | CA2135783C Substituted (arylalkoxybenzyl) amino-propanamide derivatives and process for their preparation |
| 06/07/2005 | CA2105529C Composition comprising non-steroidal anti-inflammatory agent and effectively non-antibacterial tetracycline |
| 06/07/2005 | CA2074853C 2-aralkoxy and 2-alkoxy adenosine derivatives as coronary vasodilators and antihypertensive agents |
| 06/07/2005 | CA2068790C Antiviral compounds |
| 06/07/2005 | CA2051693C Allosteric hemoglobin modifiers |
| 06/05/2005 | CA2449186A1 Generation of therapeutic regulatory dc by multiple gene silencing through induction of rna interference |
| 06/02/2005 | WO2005049850A2 Compositions and methods for systemic nucleic acid sequence delivery |
| 06/02/2005 | WO2005049827A2 Ppmp as a ceramide catabolism inhibitor for cancer treatment |
| 06/02/2005 | WO2005049822A1 Method of growing myocardial cells |
| 06/02/2005 | WO2005049648A2 Chimeric or fusion constructs of insulin-like growth factor binding proteins as chemotherapeutic agents |